BioCentury | Sep 10, 2020
Finance

Sept. 9 Quick Takes: OncoImmune, Inversago raise B rounds; plus Trillium-Pfizer, Biofourmis, LinkDoc, Singleron, Hrain, InxMed and MilleporeSigma

OncoImmune raises $56M series BOncoImmune Inc. raised $56 million in a series B round co-led by HM Capital and an undisclosed investor. Also participating were fellow new investors GBA Fund and GF Xinde, and existing...
BioCentury | Sep 9, 2019
Finance

4Bio hopes to mix and match next-gen therapies with $150M fund

4Bio Capital is aiming to invest solely in new modalities and treatment paradigms with its new venture fund, including in start-ups that combine more than one novel approach. The firm has raised $50 million in...
BioCentury | Nov 3, 2016
Financial News

Promethera completes venture financing

Promethera raised €6 million ($6.5 million) in equity in an extension of a series C round. New investors Mitsubishi UFJ Capital, Cell Innovation Partners and LifeLiver Co. Ltd., along with existing investors Vesalius Biocapital, Société...
Items per page:
1 - 3 of 3
BioCentury | Sep 10, 2020
Finance

Sept. 9 Quick Takes: OncoImmune, Inversago raise B rounds; plus Trillium-Pfizer, Biofourmis, LinkDoc, Singleron, Hrain, InxMed and MilleporeSigma

OncoImmune raises $56M series BOncoImmune Inc. raised $56 million in a series B round co-led by HM Capital and an undisclosed investor. Also participating were fellow new investors GBA Fund and GF Xinde, and existing...
BioCentury | Sep 9, 2019
Finance

4Bio hopes to mix and match next-gen therapies with $150M fund

4Bio Capital is aiming to invest solely in new modalities and treatment paradigms with its new venture fund, including in start-ups that combine more than one novel approach. The firm has raised $50 million in...
BioCentury | Nov 3, 2016
Financial News

Promethera completes venture financing

Promethera raised €6 million ($6.5 million) in equity in an extension of a series C round. New investors Mitsubishi UFJ Capital, Cell Innovation Partners and LifeLiver Co. Ltd., along with existing investors Vesalius Biocapital, Société...
Items per page:
1 - 3 of 3